{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:45:46Z","timestamp":1788871546546,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe \u00dcniversitesi","doi-asserted-by":"publisher","award":["TTU-2019-18,400"],"award-info":[{"award-number":["TTU-2019-18,400"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.placenta.2023.04.019","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T20:40:39Z","timestamp":1682541639000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-5936","authenticated-orcid":false,"given":"Mert C.","family":"Ongun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazan Vanli","family":"Tonyali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilter","family":"Deger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Celebier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nursabah E.","family":"Basci Akduman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aykan","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melih O.","family":"Babaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.placenta.2023.04.019_bib1","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"Magee","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.placenta.2023.04.019_bib2","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.placenta.2023.04.019_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11906-017-0757-7","article-title":"Pathophysiology and current clinical management of preeclampsia","volume":"19","author":"Amaral","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.placenta.2023.04.019_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00655","article-title":"Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: Windows into future cardiometabolic health?","volume":"11","author":"McElwain","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.placenta.2023.04.019_bib5","series-title":"Chesley's Hypertensive Disorders in Pregnancy","first-page":"45","article-title":"Chapter 3 - genetic factors in the etiology of preeclampsia\/eclampsia","author":"Ward","year":"2022"},{"issue":"1","key":"10.1016\/j.placenta.2023.04.019_bib6","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1038\/s41467-020-19733-6","article-title":"Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women","volume":"11","author":"Steinthorsdottir","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.placenta.2023.04.019_bib7","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2741\/4465","article-title":"Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology","volume":"21","author":"Fan","year":"2016","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.placenta.2023.04.019_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0005-2760(95)00238-3","article-title":"Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites","volume":"1300","author":"Rosolowsky","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.placenta.2023.04.019_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0022-3565(24)37530-5","article-title":"Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11","volume":"285","author":"Powell","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.placenta.2023.04.019_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.plefa.2018.02.003","article-title":"Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE)","volume":"131","author":"Kim","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.placenta.2023.04.019_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/FPC.0000000000000100","article-title":"PharmGKB summary: very important pharmacogene information for CYP4F2","volume":"25","author":"Alvarellos","year":"2015","journal-title":"Pharmacogenetics Genom."},{"issue":"3","key":"10.1016\/j.placenta.2023.04.019_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pharmthera.2009.12.002","article-title":"Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases","volume":"125","author":"Zordoky","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.placenta.2023.04.019_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/gtmb.2015.0205","article-title":"Interaction between CYP4F2 rs2108622 and CPY4A11 rs9333025 variants is significantly correlated with susceptibility to ischemic stroke and 20-hydroxyeicosatetraenoic acid level","volume":"20","author":"Liao","year":"2016","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"6","key":"10.1016\/j.placenta.2023.04.019_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/ahg.12280","article-title":"Genetic role of CYP4A11 polymorphisms in the risk of developing cardiovascular and cerebrovascular diseases","volume":"82","author":"Yu","year":"2018","journal-title":"Ann. Hum. Genet."},{"issue":"4","key":"10.1016\/j.placenta.2023.04.019_bib15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41423-021-00636-5","article-title":"Placenta-derived IL-32\u03b2 activates neutrophils to promote preeclampsia development","volume":"18","author":"Liu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.placenta.2023.04.019_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.prostaglandins.2018.03.001","article-title":"Arachidonic acid metabolites of CYP4A and CYP4F are altered in women with preeclampsia","volume":"136","author":"Plenty","year":"2018","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"12","key":"10.1016\/j.placenta.2023.04.019_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015672","article-title":"Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults","volume":"5","author":"Costea","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.placenta.2023.04.019_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023730","article-title":"Genetic variation of the human \u03b1-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.placenta.2023.04.019_bib19","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1074\/jbc.271.7.3460","article-title":"Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart","volume":"271","author":"Wu","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.placenta.2023.04.019_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/HJH.0000000000000942","article-title":"Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta","volume":"34","author":"Dalle Vedove","year":"2016","journal-title":"J. Hypertens."},{"issue":"12","key":"10.1016\/j.placenta.2023.04.019_bib21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/004982598238868","article-title":"Molecular genetics of the human cytochrome P450 monooxygenase superfamily","volume":"28","author":"Smith","year":"1998","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.placenta.2023.04.019_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0026-895X(24)12335-8","article-title":"Cloning of CYP2J2 gene and identification of functional polymorphisms","volume":"61","author":"King","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"15","key":"10.1016\/j.placenta.2023.04.019_bib23","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.CIR.0000143832.91812.60","article-title":"Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2","volume":"110","author":"Spiecker","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.placenta.2023.04.019_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clpt.2005.10.002","article-title":"A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants","volume":"79","author":"Sim","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.placenta.2023.04.019_bib25","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","article-title":"The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans","volume":"269","author":"de Morais","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.placenta.2023.04.019_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prostaglandins.2017.09.004","article-title":"Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia","volume":"134","author":"Faulkner","year":"2018","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.placenta.2023.04.019_bib27","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3892\/mmr.2014.2017","article-title":"Effect of 20-hydroxyeicosatetraenoic acid on biological behavior of human villous trophoblasts and uterine vascular smooth muscle cells","volume":"9","author":"Lu","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.placenta.2023.04.019_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ajh\/hps011","article-title":"Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies","volume":"26","author":"Jiang","year":"2013","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.placenta.2023.04.019_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00439-003-1031-4","article-title":"Excavating Y-chromosome haplotype strata in Anatolia","volume":"114","author":"Cinnio\u011flu","year":"2004","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.placenta.2023.04.019_bib30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1186\/1471-2164-15-963","article-title":"Whole genome sequencing of Turkish genomes reveals functional private alleles and impact of genetic interactions with Europe, Asia and Africa","volume":"15","author":"Alkan","year":"2014","journal-title":"BMC Genom."},{"issue":"2","key":"10.1016\/j.placenta.2023.04.019_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1469-1809.2011.00701.x","article-title":"Turkish population structure and genetic ancestry reveal relatedness among Eurasian populations","volume":"76","author":"Hodoglugil","year":"2012","journal-title":"Ann. Hum. Genet."},{"issue":"1\u20132","key":"10.1016\/j.placenta.2023.04.019_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cca.2005.08.007","article-title":"CYP2J2*7 single nucleotide polymorphism in a Chinese population","volume":"365","author":"Wang","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.placenta.2023.04.019_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4238\/2014.January.21.20","article-title":"Association of a CYP4A11 polymorphism and hypertension in the Mongolian and Han populations of China","volume":"13","author":"Liang","year":"2014","journal-title":"Genet. Mol. Res."},{"issue":"1","key":"10.1016\/j.placenta.2023.04.019_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12872-018-0837-x","article-title":"Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation","volume":"18","author":"Li","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3","key":"10.1016\/j.placenta.2023.04.019_bib35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1006\/bbrc.1998.9992","article-title":"Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population","volume":"254","author":"Yasar","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.placenta.2023.04.019_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bcpt.12710","article-title":"Decreased activity and genetic polymorphisms of CYP2C19 in behcet's disease","volume":"121","author":"Goktas","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.placenta.2023.04.019_bib37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41431-021-01004-7","article-title":"Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs","volume":"30","author":"Brouwer","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.placenta.2023.04.019_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cpt.1830","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2C9 and nonsteroidal anti-inflammatory drugs","volume":"108","author":"Theken","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.placenta.2023.04.019_bib39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/cpt.2526","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update","volume":"112","author":"Lee","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"17","key":"10.1016\/j.placenta.2023.04.019_bib40","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.3390\/jcm10173980","article-title":"Genetics variants in the epoxygenase pathway of arachidonic metabolism are associated with eicosanoids levels and the risk of diabetic nephropathy","volume":"10","author":"Mota-Zamorano","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.placenta.2023.04.019_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1152\/physiolgenomics.00003.2007","article-title":"Functional polymorphism in human CYP4F2 decreases 20-HETE production","volume":"30","author":"Stec","year":"2007","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.placenta.2023.04.019_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchromb.2012.11.004","article-title":"LC-MS\/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma: basal plasma concentrations and aspirin-induced changes of eicosanoids","volume":"911","author":"Shinde","year":"2012","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.placenta.2023.04.019_bib43","first-page":"15","article-title":"CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina","volume":"15","author":"Akasaka","year":"2017","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"3","key":"10.1016\/j.placenta.2023.04.019_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/14622416.9.3.277","article-title":"Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids","volume":"9","author":"Kirchheiner","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"15","key":"10.1016\/j.placenta.2023.04.019_bib45","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.CIR.0000143832.91812.60","article-title":"Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2","volume":"110","author":"Spiecker","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.placenta.2023.04.019_bib46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.117.10644","article-title":"Downregulated serum 14, 15-epoxyeicosatrienoic acid is associated with abdominal aortic calcification in patients with primary aldosteronism","volume":"71","author":"Liu","year":"2018","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.placenta.2023.04.019_bib47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1517\/17425250902932923","article-title":"Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology","volume":"5","author":"Kaspera","year":"2009","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"1\u20134","key":"10.1016\/j.placenta.2023.04.019_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.prostaglandins.2004.10.003","article-title":"Red blood cells: reservoirs of cis- and trans-epoxyeicosatrienoic acids","volume":"75","author":"Jiang","year":"2005","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"2","key":"10.1016\/j.placenta.2023.04.019_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.placenta.2023.04.019_bib50","doi-asserted-by":"crossref","first-page":"F221","DOI":"10.1152\/ajprenal.00170.2004","article-title":"Renal epoxyeicosatrienoic acid synthesis during pregnancy","volume":"288","author":"Zhou","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.placenta.2023.04.019_bib51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcph.631","article-title":"Pharmacokinetics of metoprolol during pregnancy and lactation","volume":"56","author":"Ryu","year":"2016","journal-title":"J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.placenta.2023.04.019_bib52","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.placenta.2023.04.019_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.abb.2004.10.009","article-title":"Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids","volume":"433","author":"Spiecker","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"issue":"15","key":"10.1016\/j.placenta.2023.04.019_bib54","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1073\/pnas.87.15.5893","article-title":"Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension","volume":"87","author":"Catella","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.placenta.2023.04.019_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mehy.2017.07.033","article-title":"The role of soluble epoxide hydrolase in preeclampsia","volume":"108","author":"Santos","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.placenta.2023.04.019_bib56","first-page":"454","article-title":"Epoxyeicosatrienoic acid metabolism in preeclampsia","volume":"40","author":"Sari","year":"2018","journal-title":"Cumhuriyet Medical Journal"},{"issue":"8","key":"10.1016\/j.placenta.2023.04.019_bib57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/1440-1681.13095","article-title":"Metabolomics revealed decreased level of omega-3 PUFA-derived protective eicosanoids in pregnant women with pre-eclampsia","volume":"46","author":"Liu","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"15","key":"10.1016\/j.placenta.2023.04.019_bib58","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.CIR.0000143832.91812.60","article-title":"Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2","volume":"110","author":"Spiecker","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.placenta.2023.04.019_bib59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41440-018-0142-1","article-title":"A comprehensive study revealed SNP-SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk","volume":"42","author":"Polonikov","year":"2019","journal-title":"Hypertens. Res."},{"issue":"7","key":"10.1016\/j.placenta.2023.04.019_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071916","article-title":"Regulation of CYP2J2 and EET levels in cardiac disease and diabetes","volume":"19","author":"Aliwarga","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.placenta.2023.04.019_bib61","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cpt.2015","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing","volume":"109","author":"Lima","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.placenta.2023.04.019_bib62","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4314\/tjpr.v18i4.24","article-title":"Association of CYP2C19*2 and *17 genetic variants with hypertension in Pakistani population","volume":"18","author":"Riaz","year":"2021","journal-title":"Trop. J. Pharmaceut. Res."},{"issue":"7","key":"10.1016\/j.placenta.2023.04.019_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002193","article-title":"Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium","volume":"7","author":"Lemaitre","year":"2011","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.placenta.2023.04.019_bib64","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2013.12.034","article-title":"Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn's disease","volume":"146","author":"Costea","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.placenta.2023.04.019_bib65","first-page":"382","article-title":"Randomised clinical trials of fish oil supplementation in high risk pregnancies","volume":"107","author":"Olsen","year":"2000","journal-title":"Fish Oil Trials In Pregnancy (FOTIP) Team, Bjog"},{"issue":"7","key":"10.1016\/j.placenta.2023.04.019_bib66","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41430-018-0290-z","article-title":"Fat intake during pregnancy and risk of preeclampsia: a prospective cohort study in Denmark","volume":"73","author":"Arvizu","year":"2019","journal-title":"Eur. J. Clin. Nutr."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400423001005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400423001005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:09:36Z","timestamp":1758910176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400423001005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":66,"alternative-id":["S0143400423001005"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2023.04.019","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2023.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}